New machine approved for adaptive RT

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 2
Volume 17
Issue 2

Siemens Medical Solutions announced it has received FDA 510(k) marketing clearance for its ARTISTE Solution, a linear accelerator engineered specifically for Adaptive Radiation Therapy (ART).

CONCORD, California—Siemens Medical Solutions announced it has received FDA 510(k) marketing clearance for its ARTISTE Solution, a linear accelerator engineered specifically for Adaptive Radiation Therapy (ART).

ARTISTE is an integrated imaging and workflow solution that provides a comprehensive portfolio of image-guided and advanced treatment delivery protocols, using multiple imaging modalities, the company said in a news release.

Articles in this issue
NLST article not balanced, critic of screening trial asserts
M.D. Anderson and AstraZeneca form neuropathic pain alliance
Good nilotinib responses in imatinib-resistant AP-CML
Virus linked to Merkel cell carcinoma
Benefit of adjuvant RT/CT for pancreatic ca affirmed
Recurrence Score helps select node+ pts for chemo
For resectable liver mets: Preop chemotherapy or not?
Plerixafor boosts stem cell mobilization in myeloma pts
MRI shows second-hand smoke damage
Assay has high sensitivity for hard-to-detect SLN mets
Dasatinib effective in imatinib resistant/intolerant CML
ONI remembers Judah Folkman, founder of angiogenesis
New machine approved for adaptive RT
ONI sits down with Dr. Vincent DeVita
Making faster, better, more cost-effective clinical trials
Recent Videos
Acupuncture
Related Content
Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.

Adding Olanzapine to Antiemetic Therapy May Help With CINV Incidence

Roman Fabbricatore
August 4th 2024
Article

Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.

Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN
May 15th 2023
Podcast

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.

Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.

Nursing-Led Palliative Cancer Care May Improve Advanced Care Planning

Hayley Virgil
April 13th 2023
Article

Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.

Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Dori Beeler, PhD;Xin Shelley Wang, MD, MPH;Viraj A. Master, MD, PhD
September 20th 2022
Podcast

Authors Dori Beeler, PhD; Shelley Wang, MD, MPH; and Viraj A. Master, MD, PhD, spoke with CancerNetwork® about a review article on cancer-related fatigue published in the journal ONCOLOGY®.

Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Matthew Fowler
August 24th 2021
Article

Positive preliminary data on FAP-2286 linked to the radionuclide lutetium-177 across a diverse array of adenocarcinomas was reported from the phase 1/2 LuMIERE trial.

Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Ariana Pelosci
August 6th 2021
Article

Trends towards missing key moments for end-of-life discussions when meeting with patients who have stage IV cancer can be overcome with existing strategies for successful EOL conversations.